ASCO is embarking on CancerLinQ, a multi-phase initiative that promises to change the way cancer is understood and treated. This “rapid learning system” will harness technological advances to connect oncology practices, measure quality and performance, and provide physicians with decision support in real time.
Cancer science and information technology are advancing rapidly, but the way we care for patients today cannot fully capitalize on those advances.
The proliferation of scientific results and novel treatments is a growing challenge for all oncology professionals as we enter the era of highly personalized cancer care. Patients are increasingly presenting with “rare cancers,” more narrowly defined by their molecular characteristics, sometimes making the best course of treatment unclear. Today more than ever, oncologists need real-time decision support to help them provide the most effective treatments tailored to their patients’ unique biology and tumors.